More on PSH
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $49.98 |
|
|||
| Open | $50.12 | ||||
| 52 Wk High | $0.10 | ||||
| 52 Wk Low | $0.10 | ||||
| Day High | $50.12 | ||||
| Day Low | $49.97 | ||||
| P/E | 333.67 | ||||
| EPS | $0.15 | ||||
| Volume | 12,095 | ||||
- Pershing Square Holdings, Ltd. Announces Appointment of Julian Ide as Independent Non-Executive Director
- Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
- Pershing Square Holdings, Ltd. Announces Completion of Investment in Howard Hughes Holdings Inc. Preferred Stock
- Pershing Square Holdings, Ltd. Notes Additional Quarterly Communications
- Pershing Square Holdings announces $100 million share buyback program
- Pershing Square Holdings launches $100 million share buyback program
- Pershing Square Holdings, Ltd. Announces Additional Share Buyback Program of $100,000,000
- Pershing Square Holdings, Ltd. Holds Annual General Meeting and Confirms Second Quarter 2026 Dividend for Shareholders
- Pershing Square Holdings to benefit from $5 billion PSUS IPO closing
- Pershing Square Holdings, Ltd. (“PSH”) Notes the Closing of Initial Public Offering of Pershing Square USA, Ltd. (“PSUS”) with Aggregate Offering Size of $5 Billion
Entities mentioned with PSH
- Pershing Square Capital | View Related Stories »
- Jefferies & Co | View Related Stories »
- Dividend | View Related Stories »
- Stock Buyback | View Related Stories »
- Definitive Agreement | View Related Stories »
- Raising Prices | View Related Stories »
- William Ackman | View Related Stories »
- IPO | View Related Stories »
- Show More...
